• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4601862)   Today's Articles (3879)   Subscriber (49365)
For: Navaneetham D, Penn AS, Howard JF, Conti-Fine BM. TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients. J Autoimmun 1998;11:621-33. [PMID: 9878084 DOI: 10.1006/jaut.1998.0246] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Number Cited by Other Article(s)
1
Marino M, Maiuri MT, Di Sante G, Scuderi F, La Carpia F, Trakas N, Provenzano C, Zisimopoulou P, Ria F, Tzartos SJ, Evoli A, Bartoccioni E. T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients. J Autoimmun 2014;52:113-21. [DOI: 10.1016/j.jaut.2013.12.007] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2013] [Accepted: 12/08/2013] [Indexed: 11/26/2022]
2
Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy. J Clin Immunol 2007;28:194-206. [PMID: 18000743 DOI: 10.1007/s10875-007-9147-2] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2007] [Accepted: 10/16/2007] [Indexed: 10/22/2022]
3
Dokai H, Nomura Y, Fujikawa Y, Nihei K, Segawa M, Shinomiya N. A study of the factors inducing the development of childhood-onset myasthenia gravis using CDR3 spectratyping analysis of the TCR repertoire. J Neuroimmunol 2007;187:192-200. [PMID: 17560663 DOI: 10.1016/j.jneuroim.2007.04.021] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2006] [Revised: 04/17/2007] [Accepted: 04/30/2007] [Indexed: 11/23/2022]
4
Tackenberg B, Kruth J, Bartholomaeus JE, Schlegel K, Oertel WH, Willcox N, Hemmer B, Sommer N. Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravis. Eur J Immunol 2007;37:849-63. [PMID: 17323412 DOI: 10.1002/eji.200636449] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
5
Matsumoto Y, Matsuo H, Sakuma H, Park IK, Tsukada Y, Kohyama K, Kondo T, Kotorii S, Shibuya N. CDR3 Spectratyping Analysis of the TCR Repertoire in Myasthenia Gravis. THE JOURNAL OF IMMUNOLOGY 2006;176:5100-7. [PMID: 16585608 DOI: 10.4049/jimmunol.176.8.5100] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
6
Lopez-Hoyos M, Bartolome-Pacheco MJ, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM. Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 2004;63:54-60. [PMID: 14672892 PMCID: PMC1754713 DOI: 10.1136/ard.2003.005900] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
7
Fernández-Mestre MT, Vargas V, Montagnani S, Cotúa M, Ogando V, Layrisse Z. HLA Class II and class I polymorphism in venezuelan patients with myasthenia gravis. Hum Immunol 2004;65:54-9. [PMID: 14700596 DOI: 10.1016/j.humimm.2003.10.003] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
8
Drachman DB, Wu JM, Miagkov A, Williams MA, Adams RN, Wu B. Specific Immunotherapy of Experimental Myasthenia by Genetically Engineered APCs. Ann N Y Acad Sci 2003;998:520-32. [PMID: 14592923 DOI: 10.1196/annals.1254.068] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
9
Chauhan B, Hutcheson PS, Slavin RG, Bellone CJ. T-cell receptor bias in patients with allergic bronchopulmonary aspergillosis. Hum Immunol 2002;63:286-94. [PMID: 12039410 DOI: 10.1016/s0198-8859(02)00361-0] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
10
Wu JM, Wu B, Miagkov A, Adams RN, Drachman DB. Specific immunotherapy of experimental myasthenia gravis in vitro: the "guided missile" strategy. Cell Immunol 2001;208:137-47. [PMID: 11333146 DOI: 10.1006/cimm.2001.1778] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
11
Drachman DB. Targeting T cells in myasthenia gravis. Ann Neurol 1999;46:553-5. [PMID: 10514090 DOI: 10.1002/1531-8249(199910)46:4<553::aid-ana1>3.0.co;2-f] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA